Pulmonary Fibrosis: Respiratory Muscle Exercises

In this video from ManagingSOB, it is discussed how to strengthen the respiratory muscles with respiratory muscle exercises. Learn more about pulmonary fibrosis: https://bit.ly/1VElTQA Pulmonary Fibrosis News is strictly a news and information website about the disease. It does not provide medical advice, diagnosis…

Galectin Therapeutics, Inc., announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its patent application “Method for Treatment of Pulmonary Fibrosis” — number 13/999,389 — on its lead compound GR-MD-02. Galectin Therapeutics is currently developing carbohydrate-based therapies…

There is currently no cure for pulmonary fibrosis and patients often face a prognosis of three to five years after diagnosis. However, medication and other treatment options can help improve patients’ quality of life. Medication for the treatment of patient with pulmonary fibrosis Nintedanib…

Fundraiser for Steve Kivlen shared this video where Dr. Howard J. Huang talks about pulmonary fibrosis and possible treatments. Learn more about pulmonary fibrosis: https://bit.ly/1VElTQA…

1. 6 Non-Pharmacological Pulmonary Fibrosis Treatments In this article, we’re focusing on bringing you non-pharmacological pulmonary fibrosis treatments. Check this list to discover 6 non-pharmacologic pulmonary fibrosis treatments. Read more about it: https://bit.ly/1SgrR74 2. Pulmonary Fibrosis: How Do Stem Cells…

Synairgen, plc, recently reported positive data from its ongoing work, in partnership with Pharmaxis, to develop a lysyl oxidase type 2 enzyme (LOXL2) inhibitor as a new treatment for idiopathic pulmonary fibrosis (IPF). The results were derived from experiments in an in vitro model of IPF, using patients’ lung cells,…

The University of Alabama, Birmingham is using smartphone technology to help patients with COPD exercise better and more safely in a bid to reduce hospital readmission rates. Learn more about pulmonary fibrosis: https://bit.ly/1VElTQA…